2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth most common cancer among men in South Korea, where the prevalence of chronic hepatitis B infection is high in middle and old age. The current practice guidelines will provide useful and sensible advice for the cl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical and molecular hepatology Jg. 28; H. 4; S. 583 - 705
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Korea (South) Korean Association for the Study of the Liver 01.10.2022
The Korean Association for the Study of the Liver
Schlagworte:
Cancer therapies
Carcinoma, Hepatocellular - diagnosis
Carcinoma, Hepatocellular - pathology
Carcinoma, Hepatocellular - therapy
Contrast agents
Disease prevention
Guideline
Hepatitis B
Hepatitis B, Chronic - complications
Hepatitis C
Humans
Liver cancer
Liver cirrhosis
Liver diseases
Liver Neoplasms - diagnosis
Liver Neoplasms - pathology
Liver Neoplasms - therapy
Male
Patients
Prevalence
Republic of Korea - epidemiology
Surveillance
Republic of Korea
United States > US
South Korea
Hepatocellular carcinoma
Diagnosis
Management
Guidelines
ISSN:2287-2728, 2287-285X, 2287-285X
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth most common cancer among men in South Korea, where the prevalence of chronic hepatitis B infection is high in middle and old age. The current practice guidelines will provide useful and sensible advice for the clinical management of patients with HCC. A total of 49 experts in the fields of hepatology, oncology, surgery, radiology, and radiation oncology from the Korean Liver Cancer Association-National Cancer Center Korea Practice Guideline Revision Committee revised the 2018 Korean guidelines and developed new recommendations that integrate the most up-to-date research findings and expert opinions. These guidelines provide useful information and direction for all clinicians, trainees, and researchers in the diagnosis and treatment of HCC.
Bibliographie:SourceType-Scholarly Journals-1
ObjectType-General Information-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
ObjectType-Instructional Material/Guideline-3
content type line 23
Editor: Seung Up Kim, Yonsei University College of Medicine, Korea
Korean Liver Cancer Association (KLCA): 1527 Gangnam Finance Plaza, 419 Teheran-ro, Gangnam-gu, Seoul 06160, Korea Tel: +82-2-313-1900, E-mail: klca@livercancer.or.kr National Cancer Center (NCC) Korea: 323 Ilsan-ro, Ilsan dong-gu, Goyang 10408, Korea Tel: +82-31-920-1605, Fax: +82-31-920-1520, E-mail: jwpark@ncc.re.kr
ISSN:2287-2728
2287-285X
2287-285X
DOI:10.3350/cmh.2022.0294